(NASDAQ: CRBU) Caribou Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.19%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.04%.
Caribou Biosciences's earnings in 2026 is -$103,403,000.On average, 8 Wall Street analysts forecast CRBU's earnings for 2026 to be -$97,537,395, with the lowest CRBU earnings forecast at -$115,569,699, and the highest CRBU earnings forecast at -$36,021,724. On average, 8 Wall Street analysts forecast CRBU's earnings for 2027 to be -$124,896,753, with the lowest CRBU earnings forecast at -$149,189,975, and the highest CRBU earnings forecast at -$36,021,724.
In 2028, CRBU is forecast to generate -$172,668,420 in earnings, with the lowest earnings forecast at -$205,924,191 and the highest earnings forecast at -$140,259,589.